The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer

Adam T. Nelczyk, Liqian Ma, Anasuya Das Gupta, Hashni Epa Vidana Gamage, Michael T. McHenry, Madeline A. Henn, Mohammed Kadiri, Yu Wang, Natalia Krawczynska, Shruti Bendre, Sisi He, Sayyed Hamed Shahoei, Zeynep Madak-Erdogan, Shih Hsuan Hsiao, Tareq Saleh, Valerie Carpenter, David A. Gewirtz, Michael J. Spinella, Erik R. Nelson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences